$AORT News

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results

Medical devices & supplies - cardiology, neurology, vascular stocks Q2 teardown: Artivion (NYSE:AORT) vs the rest

Artivion rises as Jefferies initiates at buy, sees ’attractive entry point’

Artivion (AORT) Stock May Be 13% Undervalued On Cash Flow

Jefferies Initiates Coverage On Artivion with Buy Rating, Announces Price Target of $31

Transcript: Artivion Q2 2026 Earnings Conference Call

Artivion’s (AORT) Growth Story Hides A Widening Bottom-Line Problem

3 Reasons to Avoid AORT and 1 Stock to Buy Instead

Artivion (AORT) Bounces As AMDS Launch Narrative Keeps Fair Value In Focus

Why Artivion (AORT) Stock Is Trading Up Today

Canaccord Genuity Maintains Buy on Artivion, Raises Price Target to $40

5 Revealing Analyst Questions From Artivion’s Q2 Earnings Call

Artivion (AORT) Q2 2026 Earnings Call Transcript

AORT Q2 Deep Dive: Product Momentum and Pipeline Expansion Support Positive Outlook

Artivion Q2 Earnings Call Highlights

Long-Term Growth Opportunities Remain for Artivion (AORT) Despite Challenges

Artivion Inc (AORT) (Q2 2026) Earnings Call Highlights: PMA Approval and Endospan Acquisition ...

Artivion, Inc. (AORT) Q2 2026 Earnings Call Transcript

Artivion, Inc. 2026 Q2 - Results - Earnings Call Presentation

Artivion (AORT) Q2 Earnings Meet Estimates